Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass

Genetic and pharmacological studies have defined a role for the melanocortin-4 receptor (Mc4r) in the regulation of energy homeostasis. The physiological function of Mc3r, a melanocortin receptor expressed at high levels in the hypothalamus, has remained unknown. We evaluated the potential role of Mc3r in energy homeostasis by studying Mc3r-deficient (Mc3r−/−) mice and compared the functions of Mc3r and Mc4r in mice deficient for both genes. The 4–6-month Mc3r−/− mice have increased fat mass, reduced lean mass and higher feed efficiency than wild-type littermates, despite being hypophagic and maintaining normal metabolic rates. (Feed efficiency is the ratio of weight gain to food intake.) Consistent with increased fat mass, Mc3r−/− mice are hyperleptinaemic and male Mc3r−/− mice develop mild hyperinsulinaemia. Mc3r−/− mice did not have significantly altered corticosterone or total thyroxine (T4) levels. Mice lacking both Mc3r and Mc4r become significantly heavier than Mc4r−/− mice. We conclude that Mc3r and Mc4r serve non-redundant roles in the regulation of energy homeostasis.

[1]  G. Wolff,et al.  Lipolysis in genetically obese and diabetes-prone mice. , 1970, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  W. Wilkison,et al.  The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+‐dependent mechanism , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  M. Mortrud,et al.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Bloom,et al.  The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. , 2000, The Journal of clinical investigation.

[5]  T. Kelly,et al.  DXA body composition: theory and practice. , 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  V. Chhajlani.  Distribution of cDNA for melanocortin receptor subtypes in human tissues. , 1996, Biochemistry and molecular biology international.

[7]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[8]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[9]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[10]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[11]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[12]  J. Shutter,et al.  Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.

[13]  G. Wolff,et al.  Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. , 1988, International journal of obesity.

[14]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[15]  G. Bray,et al.  Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. , 1989, Life sciences.

[16]  D. Bers,et al.  Steady-state twitch Ca2+ fluxes and cytosolic Ca2+ buffering in rabbit ventricular myocytes. , 1996, The American journal of physiology.

[17]  K. Ellis.  Human body composition: in vivo methods. , 2000, Physiological reviews.

[18]  J. Hirsch,et al.  Cellularity of adipose depots in six strains of genetically obese mice. , 1972, Journal of lipid research.

[19]  W. Wilkison,et al.  Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. , 1996, The American journal of physiology.

[20]  G. Barsh,et al.  Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain , 1999, The Journal of Neuroscience.

[21]  L. V. D. van der Ploeg,et al.  Evidence of altered hypothalamic pro-opiomelanocortin/ neuropeptide Y mRNA expression in tubby mice. , 1998, Brain research. Molecular brain research.

[22]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[23]  Y. Chagnon,et al.  Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. , 1997, The Journal of clinical investigation.

[24]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[25]  W. Wilkison,et al.  Linkage and Association Studies between the Melanocortin Receptors 4 and 5 Genes and Obesity-Related Phenotypes in the Québec Family Study , 1997, Molecular medicine.

[26]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[27]  J. Allan,et al.  Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice. , 1976, Biochimica et biophysica acta.

[28]  R. Cone,et al.  Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. , 1995, Journal of medicinal chemistry.

[29]  L. Stubbs,et al.  A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Rand,et al.  a-Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression , 2000 .